Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic status claiming more than 319K lives and affecting more than 4.81M people and counting worldwide. Considering the severity of the situation and low recovery rate many research institutions and pharmaceutical...

Full description

Bibliographic Details
Main Authors:	Abhi Bhadra, Shweta Singh, Shaswat Chandrakar, Vanshika Kumar, Sakshi Sankhla, Sayuj Raj T., E. Selvarajan
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2020-05-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	lopinavir ritonavir chloroquine hydroxychloroquine stem cell therapy cytokines remdesivir
Online Access:	https://microbiologyjournal.org/current-clinical-trials-and-vaccine-development-strategies-for-corona-virus-disease-covid-19/

Similar Items

COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-04-01)

COVID-19: An Update About the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
by: Katya Uzunova, et al.
Published: (2020-11-01)

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
by: Cristina Adriana Dehelean, et al.
Published: (2020-07-01)

Pharmacological management of COVID-19
by: Veena Raghunathan, et al.
Published: (2020-01-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
by: Subodh Kumar, et al.
Published: (2021-01-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
by: A. S. Kolbin
Published: (2020-05-01)

Therapeutic Strategies in the Management of COVID-19
by: Rajashri R. Naik, et al.
Published: (2021-02-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
by: Xinni Xu, et al.
Published: (2020-05-01)

The Effect of Proposed Drugs in the Treatment of Patients with COVID- 19: A Systematic Review
by: Amir Shakarami, et al.
Published: (2020-11-01)

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19
by: Amrit Krishna Mitra
Published: (2020-12-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
by: David Grimaldi, et al.
Published: (2020-10-01)

COVID-19 possible medical treatments
by: Marzieh Mohammadi, et al.
Published: (2021-01-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
by: Abubakar AR, et al.
Published: (2020-12-01)

Emerging pharmacotherapies for COVID-19
by: Rachana Salvi, et al.
Published: (2020-08-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
by: Stanković Biljana, et al.
Published: (2020-01-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
by: Shahamah Jomah, et al.
Published: (2020-09-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
by: Muhammad Shehryar Hussain, et al.
Published: (2020-08-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
by: Lianzhou Huang, et al.
Published: (2020-07-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
by: hasan mohammed altemimy
Published: (2020-06-01)

Antiviral treatment of COVID-19: a clinical pharmacology narrative review
by: Instiaty, et al.
Published: (2020-07-01)

A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy
by: Ana Khusnul Faizah, et al.
Published: (2020-07-01)

Review of Clinical Trials in COVID-19: Trying to Solve the Clinicians’ Conundrum
by: Amita Athavale, et al.
Published: (2020-07-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
by: B. K. Romanov
Published: (2020-09-01)

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
by: Ayşe BATIREL, et al.
Published: (2021-12-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
by: Justin T. Denholm, et al.
Published: (2020-07-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
by: Min Joo Choi, et al.
Published: (2021-01-01)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
by: Paolo Gaibani, et al.
Published: (2021-03-01)

Scoping insight on antiviral drugs against COVID-19
by: Ahmed S. Ali, et al.
Published: (2021-10-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
by: Sultan Ayoub Meo, et al.
Published: (2020-10-01)

Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review
by: Victoria Gil Martínez, et al.
Published: (2021-07-01)

Battling COVID-19: using old weapons for a new enemy
by: Rohit Kumar, et al.
Published: (2020-05-01)

Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
by: Xi Liu, et al.
Published: (2020-07-01)

The Rationale for Potential Pharmacotherapy of COVID-19
by: Maha Saber-Ayad, et al.
Published: (2020-05-01)

Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
by: Nils von Hentig, et al.
Published: (2021-05-01)

Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
by: Prasan Kumar Panda, et al.
Published: (2020-10-01)

Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
by: Panda PK, et al.
Published: (2021-09-01)

COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
by: Şule Özdemir, et al.
Published: (2020-12-01)

Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital
by: Natsuda Aumpan, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_98hl6773tqfia4sul54u83cmpf